Assessment of Cerebral Vasodilatory Capacity as Part of Catheter-Based Cerebral Angiography

dc.contributor.authorQureshi, Adnan, I
dc.contributor.authorAsif, Ahmer
dc.contributor.authorWaqas, Muhammad A.
dc.contributor.authorAytac, Emrah
dc.contributor.authorGurkas, Erdem
dc.contributor.authorSaleem, Muhammad A.
dc.contributor.authorWallery, Shawn S.
dc.date.accessioned2026-08-12T17:35:02Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractBACKGROUND AND PURPOSE Cerebral vasodilatory capacity assessment for risk stratification in patients with extracranial arterial stenosis or occlusion may be useful. We describe a new method that assesses cerebral vasodilatory capacity as part of catheter-based cerebral angiography. METHODS We prospectively assessed regional cerebral blood volume (rCBV) in the arterial distribution of interest using a controlled contrast injection in the common carotid or the subclavian arteries. rCBV maps were created using a predefined algorithm based on contrast distribution in the venous phase (voxel size: .466 mm(3)). rCBV maps were acquired again after selective administration of intra-arterial nicardipine (2.0 mg) distal to the stenosis. Two independent observers graded the change in rCBV in 10 predefined anatomical regions within the tributaries of the artery of interest (0 = reduction, 1 = no change, 2 = increase) and total rCBV change scores were summated. RESULTS Twenty-five patients with internal carotid artery stenosis (n = 18; 0-90% in severity) or extracranial vertebral artery stenosis (n = 7; 0-100% in severity) were assessed. There was an increase in rCBV in a tributary of the artery of interest in 18 of 25 after intra-arterial nicardipine (mean score: 11.98; range 0-19.5). There was no change or decrease in rCBV in 7 of 25 patients. The mean rCBV change score was similar in patients with an assessment of internal carotid artery or vertebral artery distributions (12.2 +/- 5.3; 11.4 +/- 2.5; P = .68). CONCLUSION Selective vasodilatory response to intra-arterial nicardipine in the affected arterial distribution during catheter-based cerebral angiography may provide new data for risk stratification.
dc.identifier.doi10.1111/jon.12665
dc.identifier.endpage96
dc.identifier.issn1051-2284
dc.identifier.issn1552-6569
dc.identifier.issue1
dc.identifier.orcid0000-0001-5110-2806
dc.identifier.orcid0000-0001-6786-5269
dc.identifier.pmid31565831
dc.identifier.scopus2-s2.0-85074393193
dc.identifier.scopusqualityQ2
dc.identifier.startpage90
dc.identifier.urihttps://doi.org/10.1111/jon.12665
dc.identifier.urihttps://hdl.handle.net/11508/57385
dc.identifier.volume30
dc.identifier.wosWOS:000488054200001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Neuroimaging
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectangiography
dc.subjectnicardipine
dc.subjectregional cerebral blood volume
dc.subjectvasodilatory capacity
dc.titleAssessment of Cerebral Vasodilatory Capacity as Part of Catheter-Based Cerebral Angiography
dc.typeArticle

Dosyalar